Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2 -yl)-piperidine-2,6-dione for treatment of certain leukemias

Details for Australian Patent Application No. 2012200791 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012200791

Parent 2006299431

Filing date 10 February 2012

Wipo publication date 1 March 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/425 (2006.01) - Thiazoles

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

A61K 31/515 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/02 (2006.01) Antineoplastic agents

C07H 19/20 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

23 February 2012 Complete Application Filed

1 March 2012 Application Open to Public Inspection

  Published as AU-A-2012200791

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200792-Catheter with multiple deflections

2012200790-Compositions and methods for the detection of HIV-1/HIV-2 infection